Pharmacological Modulation of AhR and NFkB with Dimethyl fumarate in Vitamin-D3-Tolerogenic Dendritic Cells derived from multiple sclerosis patients restores their properties, providing a promising combined therapy. This evidence concerns the gene AHR and multiple sclerosis.